CClinicalTrials.gg
Not yet recruitingNCT07694180Updated Jul 9, 2026

Postoperative Outcomes of Regional Blocks in Cervical Disc Surgery

An observational study in Acute Pain and Servical Disc Herniation, sponsored by Samsun University. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by Samsun University · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
66
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the postoperative analgesic efficacy of the Serratus Posterior Superior Intercostal Plane Block (SPSIP block) in patients undergoing Anterior Cervical Discectomy and Fusion (ACDF) surgery and to compare the outcomes with those of patients who do not receive regional anesthesia.

Read the detailed description

Cervical disc disorders may lead to various signs and symptoms, including neck pain, radicular pain in the upper extremities, sensory disturbances, motor weakness, and functional impairment. Anterior cervical discectomy and fusion (ACDF) is a widely accepted surgical procedure for the treatment of cervical disc herniation and other degenerative cervical spine disorders. However, postoperative pain remains a significant concern and may adversely affect recovery and patient comfort.

A multimodal analgesic approach is commonly preferred for postoperative pain management following cervical spine surgery. The incorporation of regional anesthesia techniques may reduce opioid consumption and opioid-related adverse effects while facilitating earlier mobilization, shorter hospital stay, and improved patient satisfaction.

In patients undergoing ACDF surgery, the Serratus Posterior Superior Intercostal Plane Block (SPSIPB) has emerged as a promising regional anesthesia technique for postoperative pain control. This study aims to evaluate the postoperative analgesic efficacy of SPSIPB and compare postoperative outcomes between patients receiving SPSIPB and those managed without regional anesthesia.

02

Conditions studied

  • Acute Pain
  • Servical Disc Herniation

Browse trials for

03

In context

Acute Pain

876 studies on the registry are indexed under Acute Pain; 154 are open to participants now.

This study's planned enrollment of 66 is below the median of 150 across 113 observational studies indexed under Acute Pain.

Browse Acute Pain studies →

Lead sponsor

Samsun University is the lead sponsor of 81 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients aged 18-70 years with ASA physical status I-III who are scheduled to undergo elective anterior cervical discectomy and fusion (ACDF) surgery under general anesthesia at Samsun City Hospital. Eligible patients who provide written informed consent and meet the study inclusion criteria will be enrolled consecutively during the study period

Inclusion criteria

  • Patients aged between 18 and 70 years.
  • American Society of Anesthesiologists (ASA) physical status I, II, or III.
  • Patients scheduled for elective anterior cervical discectomy and fusion (ACDF) surgery under general anesthesia.
  • Patients who provide written informed consent and agree to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of bleeding diathesis or those receiving anticoagulant therapy.
  • Patients with a known allergy or hypersensitivity to local anesthetics or opioid medications.
  • Patients with infection at the planned block site.
  • Patients with a history of previous cervical spine surgery.
  • Patients with a history of gabapentinoid or corticosteroid use within the last 3 weeks.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
66 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group-SPSİPB

    The Serratus Posterior Superior Intercostal Plane Block (SPSIPB) will be administered under ultrasound guidance 30 minutes before the induction of anesthesia for anterior cervical discectomy and fusion (ACDF) surgery.

  • Group-Control

    Patients in the control group will not receive any regional anesthesia technique before surgery and will undergo anterior cervical discectomy and fusion (ACDF) surgery under standard general anesthesia. Postoperative pain management will be provided according to the institution's routine multimodal analgesia protocol.

06

What researchers measure

Primary outcomes

  1. Opioid consumption

    Time frame: 24 hours

  2. 1. Opioid consumption

    In the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected and compared between groups.

    Time frame: 24 hours

Secondary outcomes

  1. 2. Perioperative pain intensity

    Changes in the Numerical Rating Scale (NRS) will be recorded at rest and during movement. The participant's baseline NRS will be recorded, followed by measurements before and after neuraxial positioning and up to 24 hours post-surgery. The NRS is a unidimensional measure of pain intensity in adults. It is a segmented numerical version of the Visual Analog Scale (VAS) where the participant selects a whole number (0-10) that best represents the intensity of their pain. The 11-point numerical scale ranges from '0' representing one end of the pain spectrum (e.g. 'no pain') to '10' representing the other end (e.g. 'worst imaginable pain').

    Time frame: 24 hours

  2. Quality of recovery 15 scale

    Postoperative Quality of Recovery 15 in Turkish scale. The QoR-15 (Quality of Recovery-15) questionnaire is a simple and practical tool used to assess postoperative recovery. It consists of 15 items, each scored on a numeric scale from 0 to 10, resulting in a total score ranging from 0 to 150. Based on the total score, postoperative recovery is categorized as follows: 136-150: Excellent recovery 122-135: Good recovery 90-121: Moderate recovery 0-89: Poor recovery

    Time frame: 24 hours after surgery

  3. Postoperative nausea and vomiting

    Postoperative nausea and vomiting (PONV): During follow-up, patients who experience nausea or vomiting will be evaluated using a verbal descriptive PONV scale (0=None, 1=Mild nausea, 2=Moderate nausea, 3=Single episode of vomiting, 4=More than one episode of vomiting).

    Time frame: 24 hours

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07694180
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Jul 9, 2026
Start date
Jun 22, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 2, 2027 (estimated)
Last update
Jul 9, 2026

Study contacts

HALE KEFELİ ÇELİK
Contact
ck_hale@hotmail.com
5057242409
Betül Çiftçi Kurt
Contact
betulciftcikurt@gmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion